Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 59

1.

The Profile of Long-term Parkinson's Disease Survivors with 20 Years of Disease Duration and Beyond.

Hassan A, Wu SS, Schmidt P, Simuni T, Giladi N, Miyasaki JM, Bloem BR, Malaty IA, Okun MS.

J Parkinsons Dis. 2015 Feb 26. [Epub ahead of print]

PMID:
25720446
[PubMed - as supplied by publisher]
2.

Effect of creatine monohydrate on clinical progression in patients with Parkinson disease: a randomized clinical trial.

Writing Group for the NINDS Exploratory Trials in Parkinson Disease (NET-PD) Investigators, Kieburtz K, Tilley BC, Elm JJ, Babcock D, Hauser R, Ross GW, Augustine AH, Augustine EU, Aminoff MJ, Bodis-Wollner IG, Boyd J, Cambi F, Chou K, Christine CW, Cines M, Dahodwala N, Derwent L, Dewey RB Jr, Hawthorne K, Houghton DJ, Kamp C, Leehey M, Lew MF, Liang GS, Luo ST, Mari Z, Morgan JC, Parashos S, Pérez A, Petrovitch H, Rajan S, Reichwein S, Roth JT, Schneider JS, Shannon KM, Simon DK, Simuni T, Singer C, Sudarsky L, Tanner CM, Umeh CC, Williams K, Wills AM.

JAMA. 2015 Feb 10;313(6):584-93. doi: 10.1001/jama.2015.120.

PMID:
25668262
[PubMed - indexed for MEDLINE]
3.

Is There a Role for DAT-SPECT Imaging in a Specialty Movement Disorders Practice?

Bega D, Gonzalez-Latapi P, Zadikoff C, Spies W, Simuni T.

Neurodegener Dis. 2015 Jan 15. [Epub ahead of print]

PMID:
25592727
[PubMed - as supplied by publisher]
4.

Effects of endurance exercise training on the motor and non-motor features of Parkinson's disease: a review.

Lamotte G, Rafferty MR, Prodoehl J, Kohrt WM, Comella CL, Simuni T, Corcos DM.

J Parkinsons Dis. 2015 Jan 1;5(1):21-41. doi: 10.3233/JPD-140425.

PMID:
25374272
[PubMed - in process]
5.

Overcoming obstacles to repurposing for neurodegenerative disease.

Shineman DW, Alam J, Anderson M, Black SE, Carman AJ, Cummings JL, Dacks PA, Dudley JT, Frail DE, Green A, Lane RF, Lappin D, Simuni T, Stefanacci RG, Sherer T, Fillit HM.

Ann Clin Transl Neurol. 2014 Jul;1(7):512-8. doi: 10.1002/acn3.76. Epub 2014 Jun 24.

PMID:
25356422
[PubMed]
Free PMC Article
6.

Serotonin toxicity association with concomitant antidepressants and rasagiline treatment: retrospective study (STACCATO).

Panisset M, Chen JJ, Rhyee SH, Conner J, Mathena J; STACCATO study investigators.

Pharmacotherapy. 2014 Dec;34(12):1250-8. doi: 10.1002/phar.1500. Epub 2014 Oct 14.

PMID:
25314256
[PubMed - in process]
7.

Thiazolidinediones under preclinical and early clinical development for the treatment of Parkinson's disease.

Carta AR, Simuni T.

Expert Opin Investig Drugs. 2015 Feb;24(2):219-27. doi: 10.1517/13543784.2015.963195. Epub 2014 Sep 17.

PMID:
25227476
[PubMed - in process]
8.

Cost of deep brain stimulation for the treatment of Parkinson's disease by surgical stimulation sites.

Stroupe KT, Weaver FM, Cao L, Ippolito D, Barton BR, Burnett-Zeigler IE, Holloway RG, Vickrey BG, Simuni T, Follett KA.

Mov Disord. 2014 Nov;29(13):1666-74. doi: 10.1002/mds.26029. Epub 2014 Sep 15.

PMID:
25220042
[PubMed - in process]
9.

A review of the clinical evidence for complementary and alternative therapies in Parkinson's disease.

Bega D, Gonzalez-Latapi P, Zadikoff C, Simuni T.

Curr Treat Options Neurol. 2014 Oct;16(10):314. doi: 10.1007/s11940-014-0314-5.

PMID:
25143234
[PubMed]
10.

Impact of disclosure of individual imaging results in a multi-center Parkinson clinical trial.

Jennings D, Eberly S, Oakes D, Seibyl J, Marek K, Shoulson I; Parkinson Study Group PRECEPT Investigators.

J Parkinsons Dis. 2014;4(4):629-38. doi: 10.3233/JPD-140383.

PMID:
25062961
[PubMed - in process]
11.

Recognition and treatment of depressive symptoms in Parkinson's disease: the NPF dataset.

Bega D, Wu SS, Pei Q, Schmidt PN, Simuni T.

J Parkinsons Dis. 2014;4(4):639-43. doi: 10.3233/JPD-140382.

PMID:
25035310
[PubMed - in process]
12.

Is exenatide the next big thing in Parkinson's disease?

Simuni T, Brundin P.

J Parkinsons Dis. 2014;4(3):345-7. doi: 10.3233/JPD-149001.

PMID:
24748153
[PubMed - in process]
13.

A randomized study of rotigotine dose response on 'off' time in advanced Parkinson's disease.

Nicholas AP, Borgohain R, Chaná P, Surmann E, Thompson EL, Bauer L, Whitesides J, Elmer LW; SP921 Study Investigators.

J Parkinsons Dis. 2014;4(3):361-73. doi: 10.3233/JPD-130320.

PMID:
24643203
[PubMed - in process]
14.

Circadian melatonin rhythm and excessive daytime sleepiness in Parkinson disease.

Videnovic A, Noble C, Reid KJ, Peng J, Turek FW, Marconi A, Rademaker AW, Simuni T, Zadikoff C, Zee PC.

JAMA Neurol. 2014 Apr;71(4):463-9. doi: 10.1001/jamaneurol.2013.6239.

PMID:
24566763
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Timed up and go, cognitive, and quality-of-life correlates in Parkinson's disease.

Stegemöller EL, Nocera J, Malaty I, Shelley M, Okun MS, Hass CJ; NPF Quality Improvement Initiative Investigators.

Arch Phys Med Rehabil. 2014 Apr;95(4):649-55. doi: 10.1016/j.apmr.2013.10.031. Epub 2013 Nov 27.

PMID:
24291596
[PubMed - indexed for MEDLINE]
16.

Phase II safety, tolerability, and dose selection study of isradipine as a potential disease-modifying intervention in early Parkinson's disease (STEADY-PD).

Parkinson Study Group.

Mov Disord. 2013 Nov;28(13):1823-31. doi: 10.1002/mds.25639. Epub 2013 Sep 30.

PMID:
24123224
[PubMed - indexed for MEDLINE]
17.

Association of cerebrospinal fluid β-amyloid 1-42, T-tau, P-tau181, and α-synuclein levels with clinical features of drug-naive patients with early Parkinson disease.

Kang JH, Irwin DJ, Chen-Plotkin AS, Siderowf A, Caspell C, Coffey CS, Waligórska T, Taylor P, Pan S, Frasier M, Marek K, Kieburtz K, Jennings D, Simuni T, Tanner CM, Singleton A, Toga AW, Chowdhury S, Mollenhauer B, Trojanowski JQ, Shaw LM; Parkinson's Progression Markers Initiative.

JAMA Neurol. 2013 Oct;70(10):1277-87.

PMID:
23979011
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

High rates and the risk factors for emergency room visits and hospitalization in Parkinson's disease.

Hassan A, Wu SS, Schmidt P, Dai Y, Simuni T, Giladi N, Bloem BR, Malaty IA, Okun MS; NPF-QII Investigators.

Parkinsonism Relat Disord. 2013 Nov;19(11):949-54. doi: 10.1016/j.parkreldis.2013.06.006. Epub 2013 Jul 5.

PMID:
23835430
[PubMed - indexed for MEDLINE]
19.

Rankin scale as a potential measure of global disability in early Parkinson's disease.

Simuni T, Luo ST, Chou KL, Fernandez H, He B, Parashos S.

J Clin Neurosci. 2013 Sep;20(9):1200-3. doi: 10.1016/j.jocn.2012.10.030. Epub 2013 Jun 26.

PMID:
23810387
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Implicit perceptual-motor skill learning in mild cognitive impairment and Parkinson's disease.

Gobel EW, Blomeke K, Zadikoff C, Simuni T, Weintraub S, Reber PJ.

Neuropsychology. 2013 May;27(3):314-21. doi: 10.1037/a0032305.

PMID:
23688213
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk